342 related articles for article (PubMed ID: 16717128)
1. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate.
Knights CD; Catania J; Di Giovanni S; Muratoglu S; Perez R; Swartzbeck A; Quong AA; Zhang X; Beerman T; Pestell RG; Avantaggiati ML
J Cell Biol; 2006 May; 173(4):533-44. PubMed ID: 16717128
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
3. Signaling to p53: breaking the posttranslational modification code.
Appella E; Anderson CW
Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
[TBL] [Abstract][Full Text] [Related]
4. Methylation-acetylation interplay activates p53 in response to DNA damage.
Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity.
Feng L; Lin T; Uranishi H; Gu W; Xu Y
Mol Cell Biol; 2005 Jul; 25(13):5389-95. PubMed ID: 15964796
[TBL] [Abstract][Full Text] [Related]
6. DNA damage activates p53 through a phosphorylation-acetylation cascade.
Sakaguchi K; Herrera JE; Saito S; Miki T; Bustin M; Vassilev A; Anderson CW; Appella E
Genes Dev; 1998 Sep; 12(18):2831-41. PubMed ID: 9744860
[TBL] [Abstract][Full Text] [Related]
7. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
[TBL] [Abstract][Full Text] [Related]
8. An acetylation switch in p53 mediates holo-TFIID recruitment.
Li AG; Piluso LG; Cai X; Gadd BJ; Ladurner AG; Liu X
Mol Cell; 2007 Nov; 28(3):408-21. PubMed ID: 17996705
[TBL] [Abstract][Full Text] [Related]
9. Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage.
Chao C; Wu Z; Mazur SJ; Borges H; Rossi M; Lin T; Wang JY; Anderson CW; Appella E; Xu Y
Mol Cell Biol; 2006 Sep; 26(18):6859-69. PubMed ID: 16943427
[TBL] [Abstract][Full Text] [Related]
10. Activation of p53 function by human transcriptional coactivator PC4: role of protein-protein interaction, DNA bending, and posttranslational modifications.
Batta K; Kundu TK
Mol Cell Biol; 2007 Nov; 27(21):7603-14. PubMed ID: 17785449
[TBL] [Abstract][Full Text] [Related]
11. ING5 is a Tip60 cofactor that acetylates p53 in response to DNA damage.
Liu N; Wang J; Wang J; Wang R; Liu Z; Yu Y; Lu H
Cancer Res; 2013 Jun; 73(12):3749-60. PubMed ID: 23576563
[TBL] [Abstract][Full Text] [Related]
12. Redox modulation of p53: mechanisms and functional significance.
Kim DH; Kundu JK; Surh YJ
Mol Carcinog; 2011 Apr; 50(4):222-34. PubMed ID: 21465572
[TBL] [Abstract][Full Text] [Related]
13. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
[TBL] [Abstract][Full Text] [Related]
14. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
15. The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain.
Mellert H; Sykes SM; Murphy ME; McMahon SB
Cell Cycle; 2007 Jun; 6(11):1304-6. PubMed ID: 17534149
[TBL] [Abstract][Full Text] [Related]
16. HDAC5, a key component in temporal regulation of p53-mediated transactivation in response to genotoxic stress.
Sen N; Kumari R; Singh MI; Das S
Mol Cell; 2013 Nov; 52(3):406-20. PubMed ID: 24120667
[TBL] [Abstract][Full Text] [Related]
17. Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53.
van Dieck J; Teufel DP; Jaulent AM; Fernandez-Fernandez MR; Rutherford TJ; Wyslouch-Cieszynska A; Fersht AR
J Mol Biol; 2009 Dec; 394(5):922-30. PubMed ID: 19819244
[TBL] [Abstract][Full Text] [Related]
18. Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.
Taira N; Yoshida K
Histol Histopathol; 2012 Apr; 27(4):437-43. PubMed ID: 22374721
[TBL] [Abstract][Full Text] [Related]
19. Promoter-specific p53-dependent histone acetylation following DNA damage.
Kaeser MD; Iggo RD
Oncogene; 2004 May; 23(22):4007-13. PubMed ID: 15007388
[TBL] [Abstract][Full Text] [Related]
20. Distinct pattern of p53 phosphorylation in human tumors.
Minamoto T; Buschmann T; Habelhah H; Matusevich E; Tahara H; Boerresen-Dale AL; Harris C; Sidransky D; Ronai Z
Oncogene; 2001 Jun; 20(26):3341-7. PubMed ID: 11423984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
